Reduction of ADAMTS13 Levels Predicts Mortality in SARS-CoV-2 Patients

Abstract

In SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) infected patients, hemostasis shows an uncontrolled activation, with a high D-dimer concentration.[1] [2] It has been also shown that the SARS-CoV-2 can promote endotheliitis,[3] and in turn, pulmonary endothelial damage fostering thrombogenesis.[4]